Bruderman Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$227K Buy
1,128
+207
+22% +$44.1K 0.41% 57
2022
Q1
$208K Sell
921
-164
-15% -$38.6K 0.31% 69
2021
Q4
$293K Hold
1,085
0.22% 77
2021
Q3
$262K Sell
1,085
-176
-14% -$44.4K 0.07% 107
2021
Q2
$299K Hold
1,261
0.09% 64
2021
Q1
$276K Buy
+1,261
New +$253K 0.08% 97

Other funds holding LH

Bruderman Asset Management's LH Position: Q2 2022 in Review

Bruderman Asset Management increased its Labcorp (LH) stake by 22% in Q2 2022, buying an estimated $44.1K and bringing the position to 1,128 shares worth $227K. The position accounts for 0.41% of the portfolio, ranked #57.

Bruderman Asset Management first reported a position in LH in Q1 2021 and has held it in 6 quarters since. The position peaked at $299K in Q2 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Bruderman Asset Management held 1,128 shares of Labcorp worth $227K as of Q2 2022.
  • Bruderman Asset Management bought 207 Labcorp shares in Q2 2022, an estimated $44.1K.
  • Labcorp made up 0.41% of Bruderman Asset Management's portfolio in Q2 2022, its #57 holding.
  • Bruderman Asset Management first reported a position in Labcorp in Q1 2021 and has held it in 6 quarters since.
  • Bruderman Asset Management's Labcorp position peaked at $299K in Q2 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Bruderman Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.